Lv2
130 积分 2023-07-21 加入
The hitchhiker's guide to personalized immunotherapy: How tertiary lymphoid structures predict adjuvant treatment success in HCC
2个月前
已完结
Adjuvant camrelizumab for hepatocellular carcinoma patients with high risk of recurrence after curative hepatectomy: a retrospective multicenter study
3个月前
已完结
Adjuvant camrelizumab for hepatocellular carcinoma patients with high risk of recurrence after curative hepatectomy: a retrospective multicenter study
3个月前
已关闭
Hepatectomy alters adjuvant anti-PD-1 action in a mouse model of HCC but does not compromise neoadjuvant efficacy
8个月前
已完结
Timing of first pembrolizumab infusion and long-term outcomes in non-small cell lung cancer: A retrospective multicenter study
10个月前
已完结
皖公网安备34019202002308
